Gary Musso, PhD

President at Musso and Associates LLC

Speaker

A goal-driven accomplished pharmaceutical executive with over fourty years of broad-based experience. Significant achievements in drug discovery, product development, product approval, drug delivery and regulatory affairs. Provides strategic vision for programs from inception/discovery phases through commercialization. Inventor of several patents and author of many successful regulatory filings and peer-reviewed publications. Expertise to transform science and technologies into clinically and commercially viable products in oncology, inflammation, neurology, and endocrinology. Currently, heading CMC technical and regulatory activities for multiple biotech organizations and strategic adviser to several others. Major contribution to the following approved drugs: Kyprolis®, Vyleesi®, Angiomax®, Tymlos®, Trulance®, Plenaxis®